# Angiotensin II in General Anesthesia

> **NCT03733145** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 32 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Angiotensin II

## Key facts

- **NCT ID:** NCT03733145
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-03
- **Primary completion:** 2023-03-21
- **Final completion:** 2023-03-21
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733145, "Angiotensin II in General Anesthesia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03733145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*